Matches in SemOpenAlex for { <https://semopenalex.org/work/W4240597966> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4240597966 endingPage "1586" @default.
- W4240597966 startingPage "1581" @default.
- W4240597966 abstract "OBJECTIVE: Increased frequency of hyperfibrinolytic activity was reported in patients with cirrhosis. However, the incidence, clinical presentation, and the parameters related to hyperfibrinolysis remain largely unknown in these patients. By utilizing euglobulin lysis time (ELT) and other clinical coagulation tests, the present study investigated the incidence of and clinical parameters related to hyperfibrinolytic activity, and assessed predicting factors to ε-aminocaproic acid (EACA) treatment in cirrhotic patients with hyperfibrinolysis in a liver unit. METHODS: The study included 86 consecutive patients who were referred and admitted to a referral liver unit for various liver diseases. The mean age was 50.0 yr, with a male:female ratio of 60:26. Sixty-six patients (76.7%) were Hispanic and 75 (87.2%) were cirrhotic. The etiologies of liver diseases included alcoholic liver disease (n = 68, 79.1%), hepatitis B (n = 2, 2.3%), hepatitis C (n = 6, 7.0%), autoimmune hepatitis (n = 3, 3.5%), cryptogenic liver disease (n = 4, 4.7%), and hepatocellular carcinoma (n = 3, 3.5%). Coagulation studies included ELT, PT, PTT, fibrinogen, D-dimer, and fibrin degradation product levels. RESULTS: Hyperfibrinolytic activity as reflected by shortened ELT was present in 27/75 cirrhotic (31.3%) but 0/11 noncirrhotic patients, which was significantly correlated with higher Child-Pugh (C-P) class, abnormal levels of PT, PTT, fibrinogen, platelet count, and total bilirubin. Shortened ELT was more frequently seen in patients with hepatic decompensation and mucocutaneous bleeding, although these relationships were not statistically significant. In 27 patients with hyperfibrinolysis, five (18.5%) required EACA treatment for progressive mucocutaneous bleeding and/or hematoma. EACA treatment was significantly associated with higher C-P scores; greatly shortened ELT (≤50% of normal value); and abnormal levels of fibrinogen, total bilirubin, and PT, indicating that these factors may serve as predictors for EACA treatment. CONCLUSION: Hyperfibrinolytic activity was seen in 31.3% of patients with cirrhosis, which is correlated with higher C-P scores; abnormal PT, PTT, fibrinogen level, and platelet count; and hyperbilirubinemia. Patients who received EACA treatment usually have a more severe hyperfibrinolytic activity as indicated by shortened ELT and low level of fibrinogen, and more severe liver disease as indicated by higher C-P scores and hyperbilirubinemia." @default.
- W4240597966 created "2022-05-12" @default.
- W4240597966 creator A5053853521 @default.
- W4240597966 date "2001-05-01" @default.
- W4240597966 modified "2023-10-18" @default.
- W4240597966 title "Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit" @default.
- W4240597966 doi "https://doi.org/10.1016/s0002-9270(01)02344-9" @default.
- W4240597966 hasPublicationYear "2001" @default.
- W4240597966 type Work @default.
- W4240597966 citedByCount "0" @default.
- W4240597966 crossrefType "journal-article" @default.
- W4240597966 hasAuthorship W4240597966A5053853521 @default.
- W4240597966 hasConcept C120665830 @default.
- W4240597966 hasConcept C121332964 @default.
- W4240597966 hasConcept C126322002 @default.
- W4240597966 hasConcept C2776029263 @default.
- W4240597966 hasConcept C2777075537 @default.
- W4240597966 hasConcept C2777214474 @default.
- W4240597966 hasConcept C2777382497 @default.
- W4240597966 hasConcept C2778019345 @default.
- W4240597966 hasConcept C2779036427 @default.
- W4240597966 hasConcept C2780434524 @default.
- W4240597966 hasConcept C2781219028 @default.
- W4240597966 hasConcept C61511704 @default.
- W4240597966 hasConcept C71924100 @default.
- W4240597966 hasConcept C90924648 @default.
- W4240597966 hasConceptScore W4240597966C120665830 @default.
- W4240597966 hasConceptScore W4240597966C121332964 @default.
- W4240597966 hasConceptScore W4240597966C126322002 @default.
- W4240597966 hasConceptScore W4240597966C2776029263 @default.
- W4240597966 hasConceptScore W4240597966C2777075537 @default.
- W4240597966 hasConceptScore W4240597966C2777214474 @default.
- W4240597966 hasConceptScore W4240597966C2777382497 @default.
- W4240597966 hasConceptScore W4240597966C2778019345 @default.
- W4240597966 hasConceptScore W4240597966C2779036427 @default.
- W4240597966 hasConceptScore W4240597966C2780434524 @default.
- W4240597966 hasConceptScore W4240597966C2781219028 @default.
- W4240597966 hasConceptScore W4240597966C61511704 @default.
- W4240597966 hasConceptScore W4240597966C71924100 @default.
- W4240597966 hasConceptScore W4240597966C90924648 @default.
- W4240597966 hasIssue "5" @default.
- W4240597966 hasLocation W42405979661 @default.
- W4240597966 hasOpenAccess W4240597966 @default.
- W4240597966 hasPrimaryLocation W42405979661 @default.
- W4240597966 hasRelatedWork W1972513332 @default.
- W4240597966 hasRelatedWork W2285110614 @default.
- W4240597966 hasRelatedWork W2367164280 @default.
- W4240597966 hasRelatedWork W2368201576 @default.
- W4240597966 hasRelatedWork W2376162169 @default.
- W4240597966 hasRelatedWork W2412677110 @default.
- W4240597966 hasRelatedWork W2530203677 @default.
- W4240597966 hasRelatedWork W3030616408 @default.
- W4240597966 hasRelatedWork W3041929777 @default.
- W4240597966 hasRelatedWork W4315798409 @default.
- W4240597966 hasVolume "96" @default.
- W4240597966 isParatext "false" @default.
- W4240597966 isRetracted "false" @default.
- W4240597966 workType "article" @default.